Using the polyfructose, bacterial levan, as a model polysaccharide, we anal
yzed how V regions affect binding in anti-polysaccharide mAbs. Previously,
panels of mAb were constructed from bacterial levan-immunized BALB/c and CB
A/Ca mice. The BALB/c mAb were mostly germline V(H)J606:V(kappa)11, and a s
ubset contained presumed somatic mutations in the complementarity-determini
ng regions (CDRs) that correlated with increases in avidity for the beta(2-
->1) inulin linkage of levan, The CBA/Ca mAb were more heterogeneous in V g
ene usage, but a subset of inulin-nonreactive mAb were V(H)J60G:V-A and had
V-H sequence differences in the CDRs from the V(H)J606 regions of the BALB
/c mAb, In this report, V(H)J606 Abs containing various combinations of spe
cifically mutated H and L chains were produced by engineered transfectants
and tested for inulin avidity and levan binding. Two presumed somatic mutat
ions seen in CDRs of the BALB/c hybridomas were shown to directly cause mar
ked increases in avidity for inulin (V-H N53H, 9-fold; V-L N53I, 20-fold; t
ogether, 46-fold) but not for beta(2-->6) levan, Exchange of either positio
ns 50 or 53 in V-H or the H3 loop between the BALB/c and CBA/Ca mAb resulte
d in either fine specificity shift or total loss of bacterial levan binding
, Three-dimensional models of the V regions suggested that residues that af
fect binding to inulin alone are near the edge of the CDR surface, while re
sidues involved with binding both forms of levan and affecting fine specifi
city are in the V-H:V-L junctional area.